Experience

Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…

Davis Polk advised the dealers in connection with the establishment of $2 billion medium-term note program by China Cinda (2020) I Management Limited which is a wholly owned subsidiary of…

Davis Polk advised the initial purchasers in connection with a debut Regulation S offering by Zensun Enterprises Limited of $200 million 12.5% senior notes due 2022. The notes are…

Davis Polk advised the joint lead managers on a Regulation S offering by Xi’an Aerospace High-Tech Industry Development Co., Ltd, a company incorporated in the People’s Republic of China…

Davis Polk advised the joint lead managers and joint bookrunners in connection with the initial public offering of 9,673,600 shares of common stock of Forum Engineering Inc. The shares were…

Davis Polk advised the initial purchasers in connection with a $225 million Regulation S only offering by China South City Holdings Limited of its 10.875% senior notes due 2022. CSC is a…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2023 issued by Export Development Canada. Export…

Davis Polk advised Afya Limited on its SEC-registered follow-on offering of an aggregate of 12,426,740 Class A common shares, of which 3,019,928 shares were issued and sold by Afya and…

Davis Polk advised the joint bookrunners in connection with the initial public offering by Mitre Realty Empreendimentos e Participações S.A. and the selling shareholder of 54,545,454 common…

Davis Polk advised the initial purchasers in connection with the Regulation S offering of $300 million principal amount of 8.750% senior notes due 2021 by RongXingDa Development (BVI)…